The use of Li salts in an organic solvent to in¯uence cyclization of a reactive peptide that only polymerizes in an aqueous solvent, has not been reported. Here, the selective and facile cyclization of N-chloroacetylated, C-cysteine amide peptides from the C4 domain of HIV-1 gp120 in LiCl/DMF solvent systems is demonstrated. The addition of stoichiometric amounts of Tris base to 1 mg/mL peptide in LiCl/DMF solutions was suf®cient to drive the cyclization to completion within 3 h at ambient temperatures. Cyclic peptides were the only detectable reaction products and these were con®rmed using reversed-phase HPLC and mass spectrometric analyses of the ®nal products. In aqueous solutions at pH 7.4, only polymers were obtained as judged by HPLC and SDS±PAGE. The method of using Li salts in an organic solvent to enhance the cyclization of unprotected amphipathic peptides may be useful in many situations beyond those described here. Lithium salts were reported to mediate the solubilization of peptides in organic solvents in 1989 (1) . As a nonconventional method in the synthesis of peptide compounds, Limediated solubilization of peptides would be most useful for carrying out reactions on speci®c amino acids that require aprotic, nonpolar and non-nucleophilic solvents. Although it was demonstrated using NMR that ions in¯uence peptide conformational equilibria in an organic solvent (1), the use of Li salts in an organic solvent to in¯uence the cyclization of a reactive peptide that only polymerizes in an aqueous solvent, has not been reported.
In 1987, chloroacetyl moieties, placed at the N-terminus of a fully protected synthetic peptide, were shown to remain intact following normal HF deprotection procedures (2).
Deprotected peptides, N-terminally labeled with either chloroacetyl or bromoacetyl groups, are now routinely synthesized in high yield. Such reactive leaving groups as the haloacetyl moieties would then be used to speci®cally cyclize a peptide that was N-terminally haloacetylated and contained a thiol in another position in the peptide (2±7). Nterminal haloacetylated resin-bound partially protected peptides are now used as starting materials to make libraries of cyclic peptides (8, 9) .
Previously, we showed that the N-chloroacetylated, Ccysteine amide form of the 18-amino acid C4 peptide from HIV-1 gp120 would polymerize, in a head-to-tail fashion, in an aqueous environment when the pH of the solution was brought to between 7 and 8 (10). To mimick physiological ionic strength and pH, the chloroacetylated C4 peptide could be reacted in phosphate-buffered saline, pH 7. Analytical procedures are given in the individual ®gure legends with the exception that amino acid analyses were performed as described previously using the Picotag 1 system which was used to con®rm the presence of Scarboxymethylcysteine (S-CMC) in acid hydrolsates of the cyclic peptides used here. The S-CMC con®rms the presence of the thioether that was formed when the peptides were cyclized N-terminus to C-terminus (13) .
Results
The C4-derived peptides cyclized using the approach given in this report are listed in Table 1 .
In order to learn more about the behavior of the C4 peptide in solvents that are less polar than water, several organic solvents were tested for dissolving the 18-amino acid N- Cyclic peptides often elute from reversed-phase HPLC columns earlier than the linear peptide. This is demonstrated here for the peptide used in this study. The HPLC chromatogram ( Fig. 2) clearly shows that the cyclic form is the exclusive detectable product of the reaction and there is no detectable peptomer which elutes after the linear monomer and displays multiple peaks (not shown).
The identity of the cyclic C4 peptide was con®rmed with electrospray mass spectrometry (Fig. 3) .
In summary, complete conversion of the linear Nchloroacetylated, C-cysteine amide C4 peptides to the cyclic form occurs within 3 h at ambient temperatures at a concentration of 1 mg/mL peptide in DMF with suf®cient amounts of LiCl.
Discussion
This paper describes one alternative approach that may be taken to cyclize synthetic peptides that would only polymerize in aqueous solutions. Because many peptides cyclize in water, it may not be necessary to use the method described here. However, there may be isolated cases in which cyclization is quite desirable but other solvents and/ or approaches were unsuccessful for cyclizing a particular peptide, as demonstrated here for the C4 domain of gp120.
Proof that the chloroacetylated, cysteine amide-containing peptides cyclized exclusively in LiCl/DMF was given by a combination of observations. First, the disappearance of the free sulfhydryl groups in the N-chloroacetyl, C-cysteine amide-containing peptides in solution after the addition of Tris was followed. Sulfhydryl disappearance was followed using Ellman's reagent (12) Finally, mass spectrometry con®rmed that the isolated product was of a mass consistent with a cyclized form of the linear starting material.
The exclusive cyclization of the C4 peptides used here was an unexpected surprise insofar as the intent at the outset was to synthesize peptomers having molecular masses in excess of those obtained previously in aqueous solutions (10) . In addition, from a basic chemistry viewpoint, this peptide is amphipathic and often dif®cult to handle in organic solvents or above certain concentrations in salt-containing aqueous solutions (unpublished data).
However, there are possible explanations for the exclusive cyclization of these peptides in LiCl/DMF solutions.
Peptide bonds contain strong p-character and this causes linear peptides to assume extended conformations. Cycliza- Table 1 . Peptides cyclized in LiCl/DMF
tion is thus often unfavorable since the C-and N-termini are kept apart in remote positions (14) . However, Li-salts are believed to in¯uence the p-character of the peptide carbonyl and the hydrogen bonds involving the carbonyl oxygens (1).
Therefore, in the presence of Li, unnatural conformations can be generated.
In addition, depending on the amino acid sequence of a peptide, it is reasonable to hypothesize that various side disul®de bond formation between two cysteine residues, both placed at various positions within the peptide chain (19) . For the methods described here, use of oxidizing agents, including DMSO as a solvent, are omitted in order to maintain the integrity of the free sulfhydryls so that the sulfhydryl is available for reaction with the N-chloroacetyl moiety. A key advantage of the thioether formed here over disul®des is that the thioether bond is stable in cell extracts, whereas disul®de-linked cyclic peptides are not (7) . In addition, thioether linkages were recently shown to be nonimmunogenic, a biological property that may be distinctively advantageous over other types of bond used to attach segments in cyclic peptides (22) . In contrast, the use of Li salts in DMSO with peptides having sulfhydryl groups at the N-and C-termini may be quite bene®cial for making disul®de-linked cyclic peptides.
The method of using Li salts in an organic solvent to enhance the cyclization of unprotected peptides will probably be useful in many situations involving syntheses of cyclic peptides beyond those described here. 
